Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis

Neurobiology of Disease

Volumn 43, Issue 3, 2011, Pages 678-689

  Girolamo, Francesco ^a   Ferrara, Giovanni ^b   Strippoli, Maurizio ^a   Rizzi, Marco ^a   Errede, Mariella ^a   Trojano, Maria ^a   Perris, Roberto ^c,d   Roncali, Luisa ^a   Svelto, Maria ^e   Mennini, Tiziana ^b   Virgintino, Daniela ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Cerebral cortex demyelination; Experimental autoimmune encephalomyelitis; Immunofluorescence confocal microscopy; Multiple sclerosis; Oligodendrocyte lineage; OPCs polydendrocytes

Indexed keywords

CELL PROTEIN; CYCLINE; GLUTATHIONE S TRANSFERASE ISOFORM PI; GLUTATHIONE TRANSFERASE; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE GLIAL ANTIGEN 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL COUNT; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; GLIAL RESTRICTED PROGENITOR CELL; MOUSE; MYELINATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE;

ADULT STEM CELLS; ANIMALS; CELL LINEAGE; CEREBRAL CORTEX; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA;

EID: 79960253663     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.05.021     Document Type: Article

References (97)

1. Albert M., Antel J., Brück W., Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007, 17:129-138.
2. Almolda B., Costa M., Montoya M., González B., Castellano B. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model. J. Neuroimmunol. 2009, 209:65-80.
3. Bansal R., Warrington A.E., Gard A., Ranscht B., Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies O1, O4 and R-Mab used in the analysis of oligodendrocyte development. J. Neurosci. Res. 1989, 24:548-557.
4. Baumann N., Pham-Dihn D. Biology of oligodendrocyte and myelin in the mammalian Central Nervous System. Physiol. Rev. 2001, 81:871-927.
5. Berard J.L., Wolak K., Fournier S., David S. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 2010, 58:434-445.
6. Blakemore W.F. Pattern of remyelination in the CNS. Nature 1974, 249:577-578.
7. Bø L. The histopathology of grey matter demyelination in multiple sclerosis. Acta Neurol Scand Suppl 2009, 189:51-57.
8. Bø L., Vedeler C.A., Nyland H.I., Trapp B.D., Mørk S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 2003, 62:723-732.
9. Brownell B., Hughes J.T. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962, 25:315-320.
10. Bunge M.B., Bunge R.P., Ris H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cyto 1961, 10:67-94.
11. Butovsky O., Landa G., Kunis G., Ziv Y., Avidan H., Greenberg N., et al. Induction and blockage ofoligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 2006, 116:905-915.
12. Butt A.M., Hamilton N., Hubbard P., Pugh M., Ibrahim M. Synantocytes: the fifth element. J. Anat. 2005, 207:695-706.
13. Cai Z., Lin S., Fan L.W., Pang Y., Rhodes P.G. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006, 137:425-435.
14. Cameron R.S., Rakic P. Glial cell lineage in the cerebral cortex: a review and synthesis. Glia 1991, 4:124-137.
15. Chang A., Nishiyama A., Peterson J., Prineas J., Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 2000, 20:6404-6412.
16. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med 2002, 346:165-173.
17. Chekenya M., Krakstad C., Svendsen A., Netland I.A., Staalesen V., Tysnes B.B., et al. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 2008, 27:5182-5194.
18. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 2004, 23:1168-1175.
19. Chen Y., Wu H., Wang S., Koito H., Li J., Ye F., et al. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat. Neurosci. 2009, 12:1398-1406.
20. Costa M.R., Kessaris N., Richardson W.D., Götz M., Hedin-Pereira C. The marginal zone/layer I as a novel niche for neurogenesis and gliogenesis in developing cerebral cortex. J. Neurosci. 2007, 27:11376-11388.
21. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003, 60:1157-1162.
22. Di Bello I.C., Dawson M.R.L., Levine J.M., Reynolds R. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is stimulated by demyelination rather than inflammation. J. Neurocytol. 1999, 28:365-381.
23. Franklin R.J., ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
24. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955.
25. Fruttiger M., Karlsson L., Hall A.C., Abramsson A., Calver A.R., Boström H., et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 1999, 126:457-467.
26. Ge W.P., Zhou W., Luo Q., Jan L.Y., Jan Y.N. Dividing glial cells maintain differentiated properties including complex morphology and functional synapses. Proc Natl Acad Sci U S A 2009, 106:328-333.
27. Gensert J.M., Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203.
28. Geurts J.J., Bö L., Pouwels P.J., Castelijns J.A., Polman C.H., Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005, 26:572-577.
29. Geurts J.J., Stys P.K., Minagar A., Amor S., Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J. Neurol. Sci. 2009, 282:12-20.
30. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
31. Goldman J.E. Lineages of astrocytes and oligodendrocytes. Neuroglia 2005, 72-84. Oxford University Press, New York. 2nd edn. H. Kettenmann, B.R. Ransom (Eds.).
32. Goldschmidt T., Antel J., König F.B., Brück W., Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009, 72:1914-1921.
33. Greenfield J.G., King L.S. Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 1936, 59:445-458.
34. Guardia Clausi M., Pasquini L.A., Soto E.F., Pasquini J.M. Apotransferrin-induced recovery after hypoxic/ischaemic injury on myelination. ASN Neuro 2010, 2:e00048.
35. He Y., Cai W., Wang L., Chen P. A developmental study on the expression of PDGFalphaR immunoreactive cells in the brain of postnatal rats. Neurosci. Res. 2009, 65:272-279.
36. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
37. Höftberger R., Fink S., Aboul-Enein F., Botond G., Olah J., Berki T., et al. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia 2010, 58:1847-1857.
38. Hollifield R.D., Harbige L.S., Pham-Dinh D., Sharief M.K. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Autoimmunity 2003, 36:133-141.
39. Huang J.K., Jarjour A.A., Nait Oumesmar B., Kerninon C., Williams A., Krezel W., et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 2011, 14:45-53.
40. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002, 8:1115-1121.
41. Jurynczyk M., Jurewicz A., Bielecki B., Raine C.S., Selmaj K. Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of Notch signaling. J. Neurol. Sci. 2008, 265:5-11.
42. Keirstead H.S., Blakemore W.F. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 1997, 56:1191-1201.
43. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998, 22:161-170.
44. Kidd D., Barkhof F., McConnell R., Algra P.R., Allen I.V., Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122:17-26.
45. Kim J.V., Jiang N., Tadokoro C.E., Liu L., Ransohoff R.M., Lafaille J.J., et al. Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites. J Immunol Methods 2010, 352:89-100.
46. Kremer D., Aktas O., Hartung H.P., Küry P. The complex world of oligodendroglial differentiation inhibitors. Ann. Neurol. 2011, 69:602-618.
47. Kucharova K., Stallcup W.B. The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination. Neuroscience 2010, 166:185-194.
48. Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., Brück W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008, 131:1749-1758.
49. Kukley M., Kiladze M., Tognatta R., Hans M., Swandulla D., Schramm J., et al. Glial cells are born with synapses. FASEB J. 2008, 22:2957-2969.
50. Kundu S.K., Pleatman M.A., Redwine W.A., Boyd A.E., Marcus D.M. Binding of monoclonal antibody A2B5 to gangliosides. Biochem. Biophys. Res. Commun. 1983, 116:836-842.
51. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Brück W., Rauschka H., Bergmann M., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
52. Lassmann H., Brück W., Lucchinetti C., Rodriguez M. Remyelination in multiple sclerosis. Mult. Scler. 1997, 3:133-136.
53. Lazeron R.H., Langdon D.W., Filippi M., van Waesberghe J.H., Stevenson V.L., Boringa J.B., et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta) cortical lesion on FLAIR. Mult. Scler. 2000, 6:280-285.
54. Ledeen R.W., Wu G. Nuclear sphingolipids: metabolism and signaling. J Lipid Res 2008, 49:1176-1186.
55. Levine J.M., Stincone F., Lee Y.S. Development and differentiation of glial precursor cells in the rat cerebellum. Glia 1993, 7:307-321.
56. Liu Y., Wu Y., Lee J.C., Xue H., Pevny L.H., Kaprielian Z., et al. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 2002, 40:25-43.
57. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
58. Ma J., Tanaka K.F., Shimizu T., Bernard C.C., Kakita A., Takahashi H., et al. Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. J. Neurosci. Res. 2011, 89:639-649.
59. Makagiansar I.T., Williams S., Mustelin T., Stallcup W.B. Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. J Cell Biol 2007, 178:155-165.
60. Mangiardi M., Crawford D.K., Xia X., Du S., Simon-Freeman R., Voskuhl R.R., et al. An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol 2011, 21:263-278.
61. Mangin J.M., Gallo V. The curious case of NG2 cells: transient trend or game changer?. ASN Neuro 2011, 3. pii:e00052.
62. Merkler D., Ernsting T., Kerschensteiner M., Brück W., Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 2006, 129:1972-1983.
63. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751.
64. Moll C., Mourre C., Lazdunski M., Ulrich J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res 1991, 556:311-316.
65. Nishiyama A., Lin X.H., Giese N., Heldin C.H., Stallcup W.B. Interaction between NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells is required for optimal response to PDGF. J. Neurosci. Res. 1996, 43:315-330.
66. Nishiyama A., Komitova M., Suzuki R., et al. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 2009, 10:9-22.
67. Noble M., Murray K., Stroobant P., Waterfield M.D., Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988, 333:560-562.
68. Papadopoulos D., Rundle J., Patel R., Marshall I., Stretton J., Eaton R., et al. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses. J. Neurosci. Res. 2010, 88:346-359.
69. Patani R., Balaratnam M., Vora A., Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 2007, 33:277-287.
70. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
71. Peterson J.W., Bø L., Mörk S.J., Chang A., Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 2001, 50:389-400.
72. Polito A., Reynolds R. NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J. Anat. 2005, 207:707-716.
73. Pomeroy I.M., Matthews P.M., Frank J.A., Jordan E.K., Esiri M.M. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 2005, 128:2713-2721.
74. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., Cho E.S. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 1993, 33:137-151.
75. Probstmeier R., Michels M., Franz T., Chan B.M., Pesheva P. Tenascin-R interferes with integrin-dependent oligodendrocyte precursor cell adhesion by a ganglioside-mediated signalling mechanism. Eur. J. Neurosci. 1999, 11:2474-2488.
76. Quarles R.H. Glycoprotein of myelin sheaths. J. Mol. Neurosci. 1997, 8:1-12.
77. Raff M.C., Lillien L.E., Richardson W.D., Burne J.F., Noble M.D. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 1988, 333:562-565.
78. Rasmussen S., Wang Y., Kivisäkk P., Bronson R.T., Meyer M., Imitola J., et al. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 2007, 130:2816-2829.
79. Reynolds R., Dawson M., Papadopoulos D., Polito A., Di Bello I.C., Pham-Dinh D., et al. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J. Neurocytol. 2002, 31:523-536.
80. Rudick R.A., Trapp B.D. Gray-matter injury in multiple sclerosis. N Engl J Med 2009, 361:1505-1506.
81. Simon C., Götz M., Dimou L. Progenitors in the adult cerebral cortex: cell cycle properties and regulation by physiological stimuli and injury. Glia 2011, 59:869-881.
82. Sommer I., Schachner M. Monoclonal antibodies (01 to 04) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 1981, 83:311-327.
83. Stadelmann C., Albert M., Wegner C., Brück W. Cortical pathology in multiple sclerosis. Curr. Opin. Neurol. 2008, 21:229-234.
84. Staugaitis S.M., Trapp B.D. NG2-positive glia in the human central nervous system. Neuron Glia Biol 2009, 5:35-44.
85. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007, 8:2.
86. Storch M.K., Bauer J., Linington C., Olsson T., Weissert R., Lassmann H. Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related. J. Neuropathol. Exp. Neurol. 2006, 65:1137-1142.
87. Strathmann F.G., Wang X., Mayer-Pröschel M. Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins. BMC Dev. Biol. 2007, 7:33.
88. Tansey F.A., Cammer W. A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. J. Neurochem. 1991, 57:95-102.
89. Tripathi R.B., Rivers L.E., Young K.M., Jamen F., Richardson W.D. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J. Neurosci. 2010, 30:16383-16390.
90. Tu J.L., Zhao C.B., Vollmer T., Coons S., Lin H.J., Marsh S., et al. APOE 4 polymorphism results in early cognitive deficits in an EAE model. Biochem. Biophys. Res. Commun. 2009, 384:466-470.
91. Wigley R., Hamilton N., Nishiyama A., Kirchhoff F., Butt A.M. Morphological and physiological interactions of NG2-glia with astrocytes and neurons. J. Anat. 2007, 210:661-670.
92. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 1998, 18:601-609.
93. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002, 125:338-349.
94. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990, 8:579-621.
95. Zawadzka M., Rivers L.E., Fancy S.P., Zhao C., Tripathi R., Jamen F., et al. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 2010, 6:578-590.
96. Zeis T., Kinter J., Herrero-Herranz E., Weissert R., Schaeren-Wiemers N. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes. J. Neuroimmunol. 2008, 205:10-19.
97. Zhu X., Hill R.A., Dietrich D., Komitova M., Suzuki R., Nishiyama A. Age-dependent fate and lineage restriction of single NG2 cells. Development 2011, 138:745-753.